OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Revolutionizing cancer immunotherapy: unleashing the potential of bispecific antibodies for targeted treatment
Xiaohan Guo, Yi Wu, Xue Ying, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 13

Showing 13 citing articles:

SpyMask enables combinatorial assembly of bispecific binders
C. Driscoll, Anthony H. Keeble, Mark Howarth
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 7

Matchmaking at the cell surface using bispecifics to put cells on their best behavior
C. Driscoll, Mark Howarth
Current Opinion in Biotechnology (2025) Vol. 92, pp. 103267-103267
Open Access

Enhancing activity of FcαRI-bispecific antibodies using glycoengineering
Celine Angeli Natascha Sewnath, Timon Damelang, Arthur E. H. Bentlage, et al.
The Journal of Immunology (2025)
Open Access

Current and upcoming treatment approaches to common subtypes of PTCL (PTCL NOS, ALCL, TFHs)
Alison J. Moskowitz, Robert Stuver, Steven M. Horwitz
Blood (2024) Vol. 144, Iss. 18, pp. 1887-1897
Closed Access | Times Cited: 4

Trends and Challenges in Bispecific Antibody Production
Mikhail S. Karbyshev, Irina Kalashnikova, Veronika Dubrovskaya, et al.
Journal of Chromatography A (2025), pp. 465722-465722
Closed Access

Oral delivery of protein and peptide therapeutics
Vivek P. Chavda, Pankti C. Balar
Progress in molecular biology and translational science (2025), pp. 355-387
Closed Access

Immunotherapy Influence On Human Body: Glycan Engineering Antibody-Based Cancer Treatments
Kafayat Motomori Bakare, Anyanwu Nkeiruka, Ugochukwu Okwudili Matthew, et al.
Journal of Community Medicine and Public Health Reports (2024)
Open Access | Times Cited: 2

Small Molecule Inhibitors Targeting PD-L1, CTLA4, VISTA, TIM-3, and LAG3 for Cancer Immunotherapy (2020-2024)
Binbin Cheng, Jiaoli Lv, Yao Xiao, et al.
European Journal of Medicinal Chemistry (2024) Vol. 283, pp. 117141-117141
Closed Access | Times Cited: 2

Editorial: Non-cellular immunotherapies in pediatric malignancies
Sarah Alexander, Paul Harker‐Murray, Robert J. Hayashi
Frontiers in Immunology (2024) Vol. 15
Open Access

PHE1-based IgG-like antibody platform provides a novel strategy for enhanced T-cell immunotherapy
Lingbin Wang, Haojie Jiang, Xuying Yin, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access

Bispecific T-Cell Engagers (BiTEs) in Immunotherapy
Mohsen Sheykhhasan, Anita Silas La’ah, Amirhossein Ahmadieh-Yazdi, et al.
Advances in medical diagnosis, treatment, and care (AMDTC) book series (2024), pp. 205-234
Closed Access

Humanized Recombinant Immunotoxin Targeting hCG Demonstrates Therapeutic Potential for Advanced Stage Difficult to Treat Cancers
Kirti Nain, Kritika Sonar, Sibasis Sahoo, et al.
Journal of drug targeting (2024), pp. 1-14
Closed Access

Salivary biomarkers: a promising approach for predicting immunotherapy response in head and neck cancers
Armin Nejat Dehkordi, Moein Maddahi, Parinaz Vafa, et al.
Clinical & Translational Oncology (2024)
Closed Access

Page 1

Scroll to top